Obesity Clinical Trial
Official title:
Vegetarian High Protein Weight Loss Diets
This study aims to investigate the mechanistic processes involved in protein-induced
satiety/satiation during weight loss in humans.
Thsi study will investigate:
- How do high-protein weight loss (HPWL) diets rich in meat or soya based protein sources
impact on profile of 'motivation to eat' both within a day and between days ?
- Do biomarkers of satiety alter differentially on meat or soya HPWL diet, as measured by
monitoring alteration in plasma amino acids and gut-related hormones ?
- How does a vegetarian and meat-based weight loss diet impact on nitrosamine excretion
in faecal samples, as an indicator of faecal toxicity?
Previous work has indicated that high-protein (30% protein) weight loss diets are more
satiating (produce less hunger) than normal protein WL diet (15% protein) or a diet
supplemented with few amino acids. In previous work, a mixed source of protein has been
used, mainly from meat (beef, chicken, fish). These types of diets have been criticised
because of the potential negative side effects, including our own work on gut health. It
might be that alternative vegetable sources of protein could fulfil the diet remit, to be
satiating and yet still allow weight loss, and maintain a healthy gut.
Design -within subject, randomised cross-over design after day 3. Each subject acts as their
own control and will receive each treatment. 18-20 subjects to participate.
Length of time - Conduct the two nutritional interventions over a period of 14 days, in
order to reduce effects due to an acute change in nutritional intake.
PROTOCOL Days 1- 3 - Normal Protein Maintenance diet (NP- MTD, 3 days)
1. st ARM Days 4-17 - randomised to High Protein-Weight loss-Meat (HP-Soya,14 days),
2. nd ARM Days 18-31 - randomised to High Protein-Weight loss-Soya (HP-meat,14 days),
From literature we know that:
- Within-day experiment feeding myco-protein (quorn) versus chicken at lunch resulted in
an 18% reduction in evening meal ad libitum intake following the quorn meal (Burley, P.
Blundell, 1993, Eur J Clin Nutr, 409-18).
- Feeding casein, soy, pea, wheat gluten, egg albumin, gelatin as part of a mixed meal
had no influence on post-lunch satiety (Lang et al.,1998, Am J Clin Nutr., 1197-204).
- Varying protein source (soy, caseine, gelatin) at breakfast meal at 1.8 and 3.6MJ/meal
had no impact on 24 hour energy or macronutrient intakes (Lang et al., 1999, Eur J Clin
Nutr, 959-65).
- Comparison of mycoprotein and tofu to a chicken preload before lunch indicated that the
vegetarian sources were associated with lower food intake at lunch (Williamson et al.,
2006, Appetite, 41-8).
- Addition of 25g protein in a liquid format (whey and soy) led to suppression of food
intake (pizza meal) 1 hour later, in comparison to water and whey preload.
It is noted that all of these studies, (i) were conducted over a short time period (within
day), (ii) none were high-protein weight loss diets (low calorie, high protein), (iii) none
compared mixed meat versus vegetable source. It is of interest from both a scientific and
public health point of view whether meat and vegetarian sources of protein similarly impact
on motivation to eat.
The diets for this study:
- The maintenance diet (MTD) (day 1 - 3) will consist of 15% protein, 30% fat and 55%
carbohydrate fed to 1.5 x RMR (resting metabolic rate)
- The high protein (HP) weight loss diet will be fed to 100% resting metabolic rate (RMR)
on a 5 day rotation menu, fed as three meals a day, 30% protein, 30% fat and 40%
carbohydrate; the meat version will be based on chicken and beef meat; the soya version
based on soya protein or soya-tvp (textured vegetable protein).
Soya protein is now widely available as milk (ALPRO), margarine (PURE), enhanced bread
(BURGEN), sausages (GRANOSE), bacon (GRANOSE), burgers (GRANOSE), mince (GRANOSE), powered
isolate, cheese, cream (SOYA DREAM), yoghurt (ALPRO), chicken-style fillets (GRASSINGTONS).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |